Blue Lake Biotechnology, Inc.
PrivateLast Round
Grant
Jun 13, 2024
Total Funding Raised
$46M
Company Overview
Blue Lake Biotechnology, Inc. is a biotechnology company that develops intranasal vaccines using a proprietary parainfluenza virus 5 (PIV5) vector platform to prevent serious infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Blue Lake Biotechnology, Inc. Comparables
Compare Blue Lake Biotechnology, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyanVac LLC | 96% | |
| Codagenix | 89% | |
| BlueWillow Biologics | 84% | |
Blue Lake Biotechnology, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 13, 2024 |
Blue Lake Biotechnology, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
Blue Lake Biotechnology, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Blue Lake Biotechnology, Inc.'s valuation, stock price, and market status.